Degree | Type | Year |
---|---|---|
2502442 Medicine | OB | 4 |
You can view this information at the end of this document.
Students should have acquired all the knowledge corresponding to the structure and function of the human organism.
In addition, students should have a basis of knowledge and competence in Structural Pathology, Phisiopathology, Semiology, Epidemiology and Surgery principles.
Students will acquire the commitment to preserve confidentiality and professional secrets corresponding to the data they could have access to in relationship to their learning in healthcare departments. In addition, they should maintain professional ethics in all their actions.
Medical Oncology is a medical specialty that deals with the classification, staging, treatment and comprehensive care of patients suffering from cancer.
Oncological diseases represent the second cause of death in Western countries and having knowledge of them must allow future medical graduates to have competence in the care of these patients encompassing aspects of diagnostic and therapeutic orientation, identification of the complications arising from treatment, the control of symptoms in advanced disease and at the same time some aspects about prevention.
The objectives of the subject are: 1) To acquire knowledge of the mechanisms of carcinogenesis and progression of tumor diseases; 2) Acquire knowledge of the signs and symptoms that guide diagnosis of the most frequent neoplasms; 3) Acquire knowledge about the diagnosis, classification, staging and therapeutic orientation of the most frequent neoplasms; 4) Acquire knowledge about targeted therapies, the complications of treatments; 5) Acquire skills and competencies in the multidisciplinary management of the disease and the comprehensive care of a patient with cancer
Subject 1: Introduction to Oncology. Epidemiological principles of cancer.
- Cancer as a systemic disease
- Epidemiology of cancer
- Early diagnosis
- Primary and secondary prevention
Subject 2: Diagnosis of oncological diseases (I).
- Dissemination patterns
- Staging principles
- Classification methods used
- General symptoms in advanced disease:
Subject 3: Diagnosis of oncological diseases (II).
- Bone metastases
- Cerebral metastases
- General performance
- Evaluation scales: Karnofsky index and ECOG
- Prognostic variables in cancer
- Predictive variables in cancer
Subject 4: Diagnosis of oncological diseases (III): Biomarkers.
- Biomarkers definition and their use in clinical practice
Subject 5: Hereditary cancer.
- Principles of familial cancer and principal hereditary syndromes
- Genetic Counselling principles
Subject 6: Principles of cancer treatment (I): Surgery.
- Objectives of the surgical treatment of cancer
- Radical and palliative treatment concept
- Breast cancer surgery
Subject 7: Principles of cancer treatment (II): Surgery.
- Colon cancer surgery
Subject 8: Principles of cancer treatment (III): Radiotherapy and Chemotherapy.
- Radiotherapy principles
- Chemotherapy principles
- Endocrine therapy principles
Subject 9: Principles of cancer treatment (IV): Biological therapy.
- Main signal transduction pathways
- Biological treatment principles
- Pharmacological fundamentals
- Effective biological dose concept
- Biological drug groups in solid tumours
- Mechanisms of action and applicability
Subject 10: Principles of cancer treatment (V): Immunotherapy.
- Principles of the immune system in cancer
- Primary utilities in cancer treatment:
Subject 11: Principles of cancer treatment (VI): Chemotherapy side-effects.
- Acute secondary effects
- Chronic side effects
Subject 12: Principles of cancer treatment (VII).
- Endocrine therapy side-effects
- Biological therapy side-effects
- Immunotherapy side-effects
Subject 13: Palliative care and cancer.
- Quality of life concept
- Measurement instruments and scales
- Information for cancer patients
- Terminal situation protagonists: the patient, the family and therapeutic team
- Factors contributing to suffering: physical, emotional, socialand spiritual
- Patientand family adaptation to the terminal situation: Kübler-Ross phases
Subject 14: Symptom control strategy in advanced disease (I).
- Pain:
- Respiratory symptoms
Subject 15: Symptom control strategy in advanced disease (II)
- Digestive symptoms
- Cachexia and anorexia
- Cognitive disfunction syndromes
Subject 16: Attention to the most frequent neoplasms (I): Lung Cancer.
- Epidemiology and risk factors
- Diagnosis and staging
- Treatment options: a multidisciplinary approach
- Prognosis
- Follow-up
Subject 17: Attention to the most frequent neoplasms (II): Colon and Rectal Cancer.
- Epidemiology and risk factors
- Diagnosis and staging
- Treatment options: a multidisciplinary approach
- Prognosis
- Follow-up
Subject 18: Attention to the most frequent neoplasms (III): Breast Cancer.
- Epidemiology and risk factors
- Diagnosis and staging
- Treatment options: a multidisciplinary approach
- Prognosis
- Follow-up
Subject 19: Attention to the most frequent neoplasms (IV): Prostate Cancer.
- Epidemiology and risk factors
- Diagnosis and staging
- Treatment options: a multidisciplinary approach
- Prognosis
- Follow-up
Subject 20: Oncological Emergencies
- Hypercalcemia
- Other metabolic alterations: AIDS
- Medullar compression syndrome
- Endocraneal hypertension
- Superior vena cava syndrome
Seminars Programme
Seminar A: Communication in Oncology: shared decision. Role-playing session.
- Information at diagnosis
- Information at the beginning of the disease
- Information at recurrence
- Information in advanced disease
Seminar B: Clinical research in Oncology.
- Role of clinical trials in developing new treatments
- Result evaluation methodology: RECIST method
Seminar C: Bioethics at the end of life.
Seminar D: Role of the Multidisciplinary tumour board in the definition of the diagnosis and treatment strategies. Role of the Molecular Boards.
Seminar E: Rare tumours.
- Rare tumour concept: sarcoma, central nervous system tumours, germ-cell tumours
- Tumour agnostic concept
- Role of the reference institutions
Seminar F: Clinical cases in surgery.
- Metastases surgery
- Palliative surgery
Seminar G: Clinical cases in gynecological tumours.
Seminar H: Clinical cases in melanoma/kidney and urological tumours
Title | Hours | ECTS | Learning Outcomes |
---|---|---|---|
Type: Directed | |||
Clinical Cases Seminars (SCC) | 4 | 0.16 | 8, 69, 12, 15, 23, 22, 21, 24, 25, 20, 19, 17, 31, 35, 36, 37, 38, 43, 56, 51, 48, 54, 52, 41, 47, 58, 57, 61, 62, 66, 67, 63, 68, 70, 11, 7, 5 |
Clinical simulation (PSCA) | 2 | 0.08 | 1, 24, 26, 32, 36, 46, 52, 58, 40, 67, 10, 5 |
Seminar (SEM) | 4 | 0.16 | 9, 12, 22, 24, 20, 26, 31, 32, 35, 36, 38, 51, 54, 52, 47, 58, 57, 60, 40, 70, 7, 4, 6, 5 |
Theory (TE) | 20 | 0.8 | 69, 14, 15, 23, 22, 21, 24, 25, 20, 18, 26, 30, 35, 36, 37, 38, 59, 43, 56, 51, 48, 54, 52, 47, 58, 57, 44, 40, 66, 67, 63, 68, 7, 4, 6, 5 |
Type: Supervised | |||
Hospital Care Practicum (PCAh) | 15 | 0.6 | 1, 8, 69, 9, 64, 12, 14, 15, 23, 22, 21, 24, 25, 20, 17, 18, 26, 27, 28, 33, 31, 32, 30, 35, 36, 34, 37, 43, 51, 48, 54, 46, 52, 47, 58, 57, 53, 44, 61, 40, 62, 66, 67, 63, 10, 72, 65, 71, 39, 68, 70, 11, 7, 4, 6, 5 |
Type: Autonomous | |||
Personal study, essay preparation | 50 | 2 | 69, 14, 15, 23, 22, 21, 24, 25, 20, 33, 30, 37, 43, 56, 51, 48, 54, 52, 47, 58, 57, 61, 60, 66, 67, 63, 7, 5 |
- Theory (TE): 20 hours
Group dimension: 1 Group. Number of scheduled sessions: 20
- Simulation seminar (PSCA): 2 hour
Group dimension: 10 people attending
Number of scheduled sessions: 1
- Seminars 4 hours
Group dimension: 15 people attending.
Number of scheduled sessions: 3
- Clinical Case seminars: 4 hours
Group dimension: 15 people attending.
Number of scheduled sessions: 3
- Care Practicum (PCAh)
Groups of 2-4 students
Scheduled hours: 15 hours (3 hours every day for one week)
- Autonomous work (50% of total time)
Reading of texts and articles
Study to assimilate contents
Essay preparation and presentation based on clinical cases
- Evaluation (5% of total time: 4.0 hours)
Annotation: Within the schedule set by the centre or degree programme, 15 minutes of one class will be reserved for students to evaluate their lecturers and their courses or modules through questionnaires.
Title | Weighting | Hours | ECTS | Learning Outcomes |
---|---|---|---|---|
Clinical Cases Seminars (SCC) | 5% | 0 | 0 | 1, 8, 69, 15, 23, 22, 21, 24, 20, 26, 31, 32, 35, 36, 37, 56, 51, 48, 52, 47, 58, 57, 62, 67, 63, 29, 7, 5 |
Essay presentation | 20% | 2 | 0.08 | 1, 69, 9, 64, 12, 14, 15, 23, 22, 21, 24, 25, 16, 20, 19, 17, 26, 27, 28, 31, 32, 35, 36, 34, 37, 38, 59, 43, 56, 51, 48, 55, 54, 46, 52, 41, 47, 58, 57, 50, 45, 44, 61, 60, 40, 62, 66, 67, 63, 29, 10, 72, 65, 71, 39, 68, 70, 11, 7, 3, 6, 5, 2 |
Practical evaluation | 30% | 1 | 0.04 | 8, 69, 64, 14, 15, 23, 22, 21, 24, 25, 20, 17, 18, 13, 28, 33, 31, 32, 30, 36, 37, 38, 59, 43, 49, 56, 51, 48, 55, 54, 52, 42, 47, 58, 57, 45, 44, 61, 60, 66, 67, 63, 65, 68, 11, 7, 4, 3, 6, 5, 2 |
Theory evaluation | 45% | 2 | 0.08 | 69, 64, 12, 14, 15, 23, 22, 21, 25, 16, 20, 17, 26, 30, 36, 59, 56, 51, 48, 55, 54, 52, 41, 47, 57, 53, 61, 60, 62, 66, 67, 63, 29, 68, 11, 7, 4, 6, 5 |
This subject does not provide the single assessment system
The theoretical assessment consists of 40 multiple choice questions with five possible options in which only one for each question is valid.
The practical assessment consists of 20 multiple choice questions which five possible options in which only one for each question is valid.
Each student will deliver an essay with the description of a clinical case experienced first-hand during the rotation at the end of practicum. This essay will have the following parts: a) Introduction; b) Description of the clinical case; c) Identification of problems that motivated the admission to the hospital; d) Treatment strategy; e) Evolution; f) Discussion with five references.
Full attendance to the seminars is obligatory and the total attedance will represent 5% of the final qualification. The evaluation will be made with a final question at the end of each session
Students who have not passed the continuous evaluation of the subject can resit the exam which will be announced in advance notice
Students who do not sit the exams (Theroretical and Practicum) and also the practicum will be considered as Not Evaluated and lose their right of registration for that year’s course.
National Cancer Institute [Internet]. Bethesda, MD: NCI; 2023. Available at: https://www.cancer.gov/
Sociedad Española de Oncología Médica [Internet]. Madrid: SEOM; 2023. Available at: https://www.seom.org/
American Society of Clinical Oncology [Internet]. Alexandria, VA: ASCO; 2023. Disponible en: http://www.asco.org/
European Society for Medical Oncology [Internet]. Lugano, CH: ESMO; 2023. Available at: https://www.esmo.org/
none spec¡fic software is used
Information on the teaching languages can be checked on the CONTENTS section of the guide.